Autus Asset Management, LLC Novartis Ag Transaction History

Autus Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $238,369 - $333,960	-3,373 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$84.35 - $95.37 $8,772 - $9,918	-104 Reduced 2.99%	3,373 $319,000
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $7,955 - $8,766	93 Added 2.75%	3,477 $302,000
Q2 2019 Jul 15, 2019	BUY	$75.4 - $92.8 $678 - $835	9 Added 0.27%	3,384 $309,000
Q1 2019 Apr 16, 2019	BUY	$75.32 - $86.15 $254,204 - $290,756	3,375 New	3,375 $324,000

1,433

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $210B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Autus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Autus Asset Management, LLC with notifications on news.